Notably, African Americans with or without APOE ε4 allele in the AD group had reduced levels of these CSF peptide biomarkers compared to Caucasians indicating that race and not APOE status was driving the difference in abundance (Supplemental Fig. 4A). Here, APOE is linked to Alzheimer disease.